Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
- Status
- RECRUITING
- Phase
- NA
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery
- Status
- UNKNOWN
- Phase
- N/A
Predictors of Sorafenib Response in HCC
- Status
- UNKNOWN
- Phase
- N/A
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens
- Status
- RECRUITING
- Phase
- N/A
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators
- Status
- UNKNOWN
- Phase
- N/A
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors
- Status
- RECRUITING
- Phase
- PHASE2
Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection
- Status
- UNKNOWN
- Phase
- N/A
Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2